A critical review: serum cytokines and creatinine/cystatin C ratio as prognostic biomarkers in advanced cancer patients treated with anti-PD-1/PD-L1 therapy
Supportive Care in Cancer · 2024
DOI: 10.1007/s00520-024-08751-5 ↗Kurz gefasst
Leserbrief in der Zeitschrift Supportive Care in Cancer, 2024. Verfasst von Galip Can Uyar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Ankara Etlik City Hospital, Yenimahalle, Ankara, Turkey. g.can_uyar@hotmail.com. Hauptthemen laut MEDLINE: Creatinine, Cystatin C, Cytokines, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Ankara Etlik City Hospital, Yenimahalle, Ankara, Turkey. g.can_uyar@hotmail.com.
- Department of Medical Oncology, Ankara Etlik City Hospital, Yenimahalle, Ankara, Turkey.
Zitieren
APA
Uyar, G. C., Çakmak Öksüzoğlu, Ö. B., & Sütcüoğlu, O. (2024). A critical review: serum cytokines and creatinine/cystatin C ratio as prognostic biomarkers in advanced cancer patients treated with anti-PD-1/PD-L1 therapy. Supportive Care in Cancer. https://doi.org/10.1007/s00520-024-08751-5
Vancouver
Uyar GC, Çakmak Öksüzoğlu ÖB, Sütcüoğlu O. A critical review: serum cytokines and creatinine/cystatin C ratio as prognostic biomarkers in advanced cancer patients treated with anti-PD-1/PD-L1 therapy. Supportive Care in Cancer. 2024. doi:10.1007/s00520-024-08751-5
BibTeX
@article{Uyar2024,
author = {Uyar, Galip Can and Çakmak Öksüzoğlu, Ömür Berna and Sütcüoğlu, Osman},
title = {A critical review: serum cytokines and creatinine/cystatin C ratio as prognostic biomarkers in advanced cancer patients treated with anti-PD-1/PD-L1 therapy},
journal = {Supportive Care in Cancer},
year = {2024},
doi = {10.1007/s00520-024-08751-5}
}
EUVIMED